NCT03504722 (RESCUE) is a NA clinical trial of RESCUE in PTSD, sponsored by Charleston Research Institute.

Who is sponsoring NCT03504722?

NCT03504722 is sponsored by Charleston Research Institute.

What drugs are being tested in NCT03504722?

Interventions in NCT03504722: RESCUE, Prolonged Exposure.

Is NCT03504722 still recruiting?

NCT03504722 is currently completed. Last updated 22 January 2020.

Last reviewed 2020-01-22 · How we verify

NCT03504722: RESCUE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluating the Feasibility of RESCUE: An Adjunctive HAI-Based Intervention for Veterans With PTSD

Completed NA Last updated 22 January 2020

What this trial tests

NA trial testing RESCUE in PTSD in 57 participants. Completed in 1 September 2019.

Timeline

27 September 2016

Primary endpoint
31 August 2019

1 September 2019

Quick facts

Lead sponsor	Charleston Research Institute
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	57
Start date	27 September 2016
Primary completion	31 August 2019
Estimated completion	1 September 2019
Sites	1 location across United States

Drugs / interventions tested

RESCUE — full drug profile →
Prolonged Exposure

Conditions studied

PTSD — all drugs for PTSD →

Sponsor

Charleston Research Institute

Who can join

Adults 18 to 65, any sex, with PTSD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To develop and pilot test feasibility, acceptability, and efficacy of an adjunct intervention for use with Empirically Based Treatments (EBT) for posttraumatic stress disorder (PTSD) in order to increase treatment engagement, treatment completion, and improve treatment response regarding emotional numbing symptoms. Recovery through Engagement with Shelter Canines, Understanding, and Exposure (RESCUE), is an adjunctive, Human Animal Interaction (HAI) intervention that will be developed for integration into Prolonged Exposure (PE) treatment. Feasibility, acceptability, and initial efficacy testing of the experimental treatment condition will be conducted in a pilot crossover randomized controlled trial (RCT) conducted with 75 veterans with PTSD randomly assigned to RESCUE delivered with PE (RESCUE+PE) or to standard PE initiation (PE + delayed RESCUE).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

An adjunctive human-animal interaction intervention for veterans with PTSD: study protocol for a randomized controlled trial.
Grubaugh AL, Myers US, Keller SM, Wangelin BC, et al · · 2019 · cited 2× · PMID 31881993 · DOI 10.1186/s13063-019-3877-3

Verify or expand the search:

Other trials of RESCUE

Trials testing the same drug.

NCT06779617 — UMMS Sepsis Early Prediction Score (SEPSys) and RESCUE Score Combined Clinical Trial · NA · not yet recruiting

Other recruiting trials for PTSD

Currently open trials in the same condition.

NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
NCT07010757 — Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial · NA · recruiting
NCT07372586 — Behavioral Health Collaborative Care Model in an ICU Recovery Clinic · NA · recruiting
NCT07390786 — Behavioral Health Collaborative Care Model in Post-ICU Clinic Family Pilot · NA · recruiting
NCT07469098 — Group vs Individual MDMA-Assisted Therapy for PTSD After the October 7, 2023 Events · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03504722 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Charleston Research Institute
Last refreshed: 22 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03504722.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing